Severe anemia and seborrhea in an 18-month-old child

Clinical Pediatrics

Volumn 50, Issue 11, 2011, Pages 1078-1081

  Brumfield, Emily K ^a   Steele, Russell W ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; PREDNISONE; VINBLASTINE;

ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE TRANSFUSION; FAILURE TO THRIVE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; PANCYTOPENIA; PETECHIA; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SEBORRHEIC DERMATITIS; SKIN BIOPSY; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; TYMPANOSTOMY TUBE;

ANEMIA; DERMATITIS, SEBORRHEIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; SEVERITY OF ILLNESS INDEX;

EID: 80054799725     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922811409030     Document Type: Article

References (15)

1. Johns Hopkins: The Harriet Lane Handbook. 18 th ed.Philadelphia, PA: Elsevier Mosby; 2009. Custer JW Rau RE, ed. Philadelphia, PA: Elsevier Mosby ; 2009 :
2. Rosso DA, Roy A, Zelazko M, Braier JL. Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis. Br J Haematol. 2002 ; 117: 54-58 (Pubitemid 34304421)
3. Histiocytic Disorders of Children and Adults. Weizter S Egeler RM, ed. Cambridge, England: Cambridge University Press ; 2005 :
4. Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 2001 ; 25: 630-636 (Pubitemid 32423361)
5. McClain KL, Laud P, Wu WS, Pollack MS. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 phenotypes associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med Pediatr Oncol. 2003 ; 41: 502-507 (Pubitemid 37386066)
6. Grois NG, Favara BE, Mostbeck GH, Prayer D.. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998 ; 12: 287-305 (Pubitemid 28175881)
7. Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med. 2000 ; 343: 998-1007
8. Fleischer AB. Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis. Clin Pediatr (Phila). 2008 ; 47: 332-346
9. Dehner LP. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol. 2005 ; 29: 21-28
10. Freyer DR, Kennedy R, Bostrom BC, Kohut G, Dehner LP. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996 ; 129: 227-237 (Pubitemid 27483794)
11. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996 ; 75: 157-169 (Pubitemid 26159212)
12. Janka GE. Hemophagocytic syndromes. Blood Rev. 2007 ; 21: 245-253 (Pubitemid 47212601)
13. Weitzman S, Braier J, Donadieu J, et al. 2′-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). Results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer. 2009 ; 53: 1271-1276
14. Akkari V, Donadieu J, Piguet C, et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant. 2003 ; 31: 1097-1103 (Pubitemid 36857367)
15. Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2005 ; 36: 215-225 (Pubitemid 41136293)